Style | Citing Format |
---|---|
MLA | Markov A, et al.. "Retraction Note: Mesenchymal Stem/Stromal Cells As a Valuable Source for the Treatment of Immune-Mediated Disorders (Stem Cell Research & Therapy, (2021), 12, 1, (192), 10.1186/S13287-021-02265-1)." Stem Cell Research and Therapy, vol. 15, no. 1, 2024, pp. -. |
APA | Markov A, Thangavelu L, Aravindhan S, Zekiy AO, Jarahian M, Chartrand MS, Pathak Y, Marofi F, Shamlou S, Hassanzadeh A (2024). Retraction Note: Mesenchymal Stem/Stromal Cells As a Valuable Source for the Treatment of Immune-Mediated Disorders (Stem Cell Research & Therapy, (2021), 12, 1, (192), 10.1186/S13287-021-02265-1). Stem Cell Research and Therapy, 15(1), -. |
Chicago | Markov A, Thangavelu L, Aravindhan S, Zekiy AO, Jarahian M, Chartrand MS, Pathak Y, Marofi F, Shamlou S, Hassanzadeh A. "Retraction Note: Mesenchymal Stem/Stromal Cells As a Valuable Source for the Treatment of Immune-Mediated Disorders (Stem Cell Research & Therapy, (2021), 12, 1, (192), 10.1186/S13287-021-02265-1)." Stem Cell Research and Therapy 15, no. 1 (2024): -. |
Harvard | Markov A et al. (2024) 'Retraction Note: Mesenchymal Stem/Stromal Cells As a Valuable Source for the Treatment of Immune-Mediated Disorders (Stem Cell Research & Therapy, (2021), 12, 1, (192), 10.1186/S13287-021-02265-1)', Stem Cell Research and Therapy, 15(1), pp. -. |
Vancouver | Markov A, Thangavelu L, Aravindhan S, Zekiy AO, Jarahian M, Chartrand MS, et al.. Retraction Note: Mesenchymal Stem/Stromal Cells As a Valuable Source for the Treatment of Immune-Mediated Disorders (Stem Cell Research & Therapy, (2021), 12, 1, (192), 10.1186/S13287-021-02265-1). Stem Cell Research and Therapy. 2024;15(1):-. |
BibTex | @article{ author = {Markov A and Thangavelu L and Aravindhan S and Zekiy AO and Jarahian M and Chartrand MS and Pathak Y and Marofi F and Shamlou S and Hassanzadeh A}, title = {Retraction Note: Mesenchymal Stem/Stromal Cells As a Valuable Source for the Treatment of Immune-Mediated Disorders (Stem Cell Research & Therapy, (2021), 12, 1, (192), 10.1186/S13287-021-02265-1)}, journal = {Stem Cell Research and Therapy}, volume = {15}, number = {1}, pages = {-}, year = {2024} } |
RIS | TY - JOUR AU - Markov A AU - Thangavelu L AU - Aravindhan S AU - Zekiy AO AU - Jarahian M AU - Chartrand MS AU - Pathak Y AU - Marofi F AU - Shamlou S AU - Hassanzadeh A TI - Retraction Note: Mesenchymal Stem/Stromal Cells As a Valuable Source for the Treatment of Immune-Mediated Disorders (Stem Cell Research & Therapy, (2021), 12, 1, (192), 10.1186/S13287-021-02265-1) JO - Stem Cell Research and Therapy VL - 15 IS - 1 SP - EP - PY - 2024 ER - |